Vaccine companies are testing their shots against the variant of concern—and some early data is beginning to emerge.
In a joint press release, the companies said that the study involved looking at blood samples from people who had received either two or three Pfizer vaccine shots, but did not disclose the sample size or how many people the samples were taken from.
The study found there was a 41-fold reduction in neutralization against Omicron compared to an earlier form of SARS-CoV-2, a substantial decrease—though it does not mean the vaccine is 41 times less effective.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Pfizer, BioNTech say initial lab study showed 3 doses of COVID-19 vaccine neutralized omicron variantPfizer Inc. undefined and BioNTech SE undefined said results from an 'initial laboratory study' showed that their COVID-19 vaccine neutralized the omicron...
Lire la suite »
Pfizer says COVID booster offers protection against omicronPfizer says a booster dose of its COVID-19 vaccine may protect against the new omicron variant.
Lire la suite »
Pfizer says booster dose of vaccine protects against omicron variantPfizer-BioNTech announced early results of how well its vaccine works against the omicron variant. Does the Pfizer vaccine work against omicron?
Lire la suite »
Symptoms, vaccine evasion and a new 'offshoot': What we know now about the omicron Covid variantDay by day, more information has emerged regarding the spread of the variant, as well as anecdotal evidence and preliminary data about its risk profile.
Lire la suite »
Dow jumps nearly 650 points, erasing last week’s losses as investors shake off omicron worriesStocks rallied to start to the week Monday, with the Dow erasing its losses from the previous weeks, as investors shook off fears around the emerging threat of omicron. The Dow surged 1.87%. The S&P 500 was up 1.18%. The Nasdaq rose 0.93%.
Lire la suite »
Treasury yields inch higher as omicron variant fears easeU.S. Treasury yields rose on Tuesday morning, as concerns eased around the omicron Covid variant.
Lire la suite »